Vaccines Market Growth Opportunities & Forecast till 2032

Feb, 2025 Healthcare

Vaccines Market Growth Opportunities and Forecast till 2032

Category by- Healthcare , No. of Pages - 250, Published By -

CHAPTER 1. Industry Overview of Vaccines Market

1.1. Definition and Scope
1.1.1. Definition of Vaccines
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Vaccines Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Vaccines Market By Type
1.2.3. Vaccines Market By Indication
1.2.4. Vaccines Market By Technology
1.2.5. Vaccines Market By Route of Administration
1.2.6. Vaccines Market By Regions

CHAPTER 2. Research Approach

2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Distribution Channel
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Vaccines Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Vaccines Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2023
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Vaccines Market By Type

4.1. Introduction
4.2. Vaccines Revenue By Type
4.2.1. Vaccines Market Revenue (USD Million) and Forecast, By Type, 2020-2032
4.2.2. Monovalent
4.2.2.1. Monovalent Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.3. Multivalent
4.2.3.1. Multivalent Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 5. Vaccines Market By Indication

5.1. Introduction
5.2. Vaccines Revenue By Indication
5.2.1. Vaccines Market Revenue (USD Million) and Forecast, By Indication, 2020-2032
5.2.2. Viral Diseases
5.2.2.1. Viral Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2. Hepatitis
5.2.2.2.1. Hepatitis Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.3. HPV
5.2.2.3.1. HPV Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.4. Influenza
5.2.2.4.1. Influenza Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.5. Rotavirus
5.2.2.5.1. Rotavirus Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.6. MMR
5.2.2.6.1. MMR Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.7. Dengue
5.2.2.7.1. Dengue Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.8. Others
5.2.2.8.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Bacterial Vaccines
5.2.3.1. Bacterial Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.2. Meningococcal
5.2.3.2.1. Meningococcal Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.3. Pneumococcal
5.2.3.3.1. Pneumococcal Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.4. DPT
5.2.3.4.1. DPT Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.5. Others
5.2.3.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Cancer Vaccines
5.2.4.1. Cancer Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Allergy Vaccines
5.2.5.1. Allergy Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Vaccines Market By Technology

6.1. Introduction
6.2. Vaccines Revenue By Technology
6.2.1. Vaccines Market Revenue (USD Million) and Forecast, By Technology, 2020-2032
6.2.2. Conjugate Vaccines
6.2.2.1. Conjugate Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Inactivated Vaccines
6.2.3.1. Inactivated Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Live Attenuated Vaccines
6.2.4.1. Live Attenuated Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Toxoid Vaccines
6.2.5.1. Toxoid Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.6. Recombinant Vaccines
6.2.6.1. Recombinant Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. Vaccines Market By Route of Administration

7.1. Introduction
7.2. Vaccines Revenue By Route of Administration
7.2.1. Vaccines Market Revenue (USD Million) and Forecast, By Route of Administration, 2020-2032
7.2.2. Oral
7.2.2.1. Oral Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Intramuscular
7.2.3.1. Intramuscular Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Subcutaneous
7.2.4.1. Subcutaneous Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.5. Others
7.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Vaccines Market By Country

8.1. North America Vaccines Market Overview
8.2. U.S.
8.2.1. U.S. Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
8.2.2. U.S. Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
8.2.3. U.S. Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
8.2.4. U.S. Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.3. Canada
8.3.1. Canada Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
8.3.2. Canada Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
8.3.3. Canada Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
8.3.4. Canada Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
8.4. North America PEST Analysis

CHAPTER 9. Europe Vaccines Market By Country

9.1. Europe Vaccines Market Overview
9.2. U.K.
9.2.1. U.K. Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
9.2.2. U.K. Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
9.2.3. U.K. Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.2.4. U.K. Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.3. Germany
9.3.1. Germany Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
9.3.2. Germany Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
9.3.3. Germany Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.3.4. Germany Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.4. France
9.4.1. France Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
9.4.2. France Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
9.4.3. France Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.4.4. France Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.5. Spain
9.5.1. Spain Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
9.5.2. Spain Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
9.5.3. Spain Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.5.4. Spain Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
9.6.2. Rest of Europe Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
9.6.3. Rest of Europe Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
9.6.4. Rest of Europe Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

CHAPTER 10. Asia Pacific Vaccines Market By Country

10.1. Asia Pacific Vaccines Market Overview
10.2. China
10.2.1. China Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
10.2.2. China Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
10.2.3. China Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.2.4. China Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.3. Japan
10.3.1. Japan Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
10.3.2. Japan Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
10.3.3. Japan Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.3.4. Japan Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.4. India
10.4.1. India Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
10.4.2. India Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
10.4.3. India Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.4.4. India Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.5. Australia
10.5.1. Australia Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
10.5.2. Australia Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
10.5.3. Australia Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.5.4. Australia Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.6. South Korea
10.6.1. South Korea Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
10.6.2. South Korea Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
10.6.3. South Korea Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.6.4. South Korea Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
10.7.2. Rest of Asia-Pacific Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
10.7.3. Rest of Asia-Pacific Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
10.7.4. Rest of Asia-Pacific Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Vaccines Market By Country

11.1. Latin America Vaccines Market Overview
11.2. Brazil
11.2.1. Brazil Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
11.2.2. Brazil Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
11.2.3. Brazil Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
11.2.4. Brazil Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.3. Mexico
11.3.1. Mexico Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
11.3.2. Mexico Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
11.3.3. Mexico Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
11.3.4. Mexico Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
11.4.2. Rest of Latin America Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
11.4.3. Rest of Latin America Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
11.4.4. Rest of Latin America Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Vaccines Market By Country

12.1. Middle East & Africa Vaccines Market Overview
12.2. GCC
12.2.1. GCC Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
12.2.2. GCC Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
12.2.3. GCC Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
12.2.4. GCC Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
12.3. South Africa
12.3.1. South Africa Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
12.3.2. South Africa Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
12.3.3. South Africa Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
12.3.4. South Africa Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-20324
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Vaccines Market Revenue (USD Million) and Forecast By Type, 2020-2032
12.4.2. Rest of Middle East & Africa Vaccines Market Revenue (USD Million) and Forecast By Indication, 2020-2032
12.4.3. Rest of Middle East & Africa Vaccines Market Revenue (USD Million) and Forecast By Technology, 2020-2032
12.4.4. Rest of Middle East & Africa Vaccines Market Revenue (USD Million) and Forecast By Route of Administration, 2020-2032
12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Vaccines

13.1. Vaccines Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Vaccines Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. COMPANY PROFILE

14.1. AstraZeneca
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2023
14.1.3.2. AstraZeneca, 2023 Vaccines Business Regional Distribution
14.1.4. Product / Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. BioNTech SE
14.3. GSK Plc.
14.4. Merck & Co., Inc.
14.5. Moderna Inc.
14.6. Pfizer Inc.
14.7. Sanofi
14.8. Sinovac
14.9. Seqirus
14.10. Serum Institute of India Pvt. Ltd.

Quick Buy

Request Sample Check Discount Enquiry Before Buying